This topic contains a solution. Click here to go to the answer

Author Question: One criticism of plea bargaining is that it wastes time; most defendants pleadguilty anyway. a. ... (Read 162 times)

genevieve1028

  • Hero Member
  • *****
  • Posts: 601
One criticism of plea bargaining is that it wastes time; most defendants pleadguilty anyway.
 
  a. True b. False

Question 2

It has been known for some time that the CIA has also involved in paramilitary operations.
 
  a. True
  b. False



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wergv

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

a

Answer to Question 2

B




genevieve1028

  • Member
  • Posts: 601
Reply 2 on: Aug 23, 2018
Great answer, keep it coming :)


milbourne11

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Excellent

 

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library